Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients - Test2 - elhamkhani - TriplyDB

Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients

Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients

http://www.wikidata.org/entity/Q24554505

about

The novel cellular mechanism of human 5-HT6 receptor through an interaction with Fyn Drug Development in Alzheimer's Disease: The Contribution of PET and SPECT Monoaminergic and Histaminergic Strategies and Treatments in Brain Diseases Hospital-diagnosed dementia and suicide: a longitudinal study using prospective, nationwide register data Cellular and molecular actions of Methylene Blue in the nervous system Citalopram for agitation in Alzheimer's disease: design and methods.Ovarian hormones ameliorate memory impairment, cholinergic deficit, neuronal apoptosis and astrogliosis in a rat model of Alzheimer's disease.The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component.The serotonergic system and cognitive function Merkel disc is a serotonergic synapse in the epidermis for transmitting tactile signals in mammals.ADN-1184 a monoaminergic ligand with 5-HT(6/7) receptor antagonist activity: pharmacological profile and potential therapeutic utility.Current therapeutic targets for the treatment of Alzheimer's disease.Localization of 5-HT1A and 5-HT2A positive cells in the brainstems of control age-matched and Alzheimer individuals.5-Hydroxytryptamine 6 Receptor (5-HT6R)-Mediated Morphological Changes via RhoA-Dependent Pathways.Branched-chain amino acids and Alzheimer's disease: a Mendelian randomization analysis.Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice.TUNEL and growth factor expression in the prefrontal cortex of Alzheimer patients over 80 years old.Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.Interactions of Hallucinogens with the Glutamatergic System: Permissive Network Effects Mediated Through Cortical Layer V Pyramidal Neurons.A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil.

P2860

Q24338247-CB376A58-6AE0-4859-962B-D12A39B88FF6 Q26749755-61D290D6-9C99-4813-B7D7-149C2269078E Q28066691-8286652C-DA20-42FB-9F0B-A14EE69D9406 Q31148169-64C45CB8-D3CD-4A86-8D3F-C99F55424A4E Q34422385-D0974229-B6CD-4619-A922-12567C48F1C1 Q35905635-BAD09D20-3678-4B96-B993-531CED19FAEF Q36502046-2485BB92-EE7B-42AA-8A9B-498825AE0EFC Q36569606-555E7FC8-E4AA-451E-9B7D-4BA2A8FE8E19 Q37245282-6DF71B23-83FA-4022-A243-BA0C357878ED Q37264205-C427390E-5529-47C4-9E87-20DA4973927A Q37585410-9B8CC8A4-B726-4EC0-916A-599EE028F327 Q37737296-8EF4484D-81A1-453A-ABA1-32338F9FC4D3 Q39868918-D43507EA-B0A2-4246-B775-3ABA74A25049 Q41288613-E56DBE6C-864E-4D17-88F2-876FE3019D51 Q42670442-E4E0ED63-0E6B-4BB5-91C1-D18397351096 Q42970617-450059DD-92BD-459D-921E-10FA74CA481F Q43105943-FBAFF8C3-4510-40ED-80B8-E10D5A63C246 Q47557467-B977AB7C-1281-4F73-A5D5-95A2987F3E91 Q48143733-56485041-2F2F-4B3C-804F-379D26CAC349 Q55304897-33D55A83-6852-4C7C-A503-77F1CE0BF9BD

P2860

Serotonin 5-HT2A and 5-HT6 receptors in the prefrontal cortex of Alzheimer and normal aging patients

http://www.wikidata.org/entity/Q24554505

description

2006 nî lūn-bûn

@nan

2006 թուականին հրատարակուած գիտական յօդուած

@hyw

2006 թվականին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@ast

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@en

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@nl

type

label

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@ast

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@en

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@nl

prefLabel

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@ast

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@en

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@nl

P1433

Q24554505-266EEA64-D51B-48B1-A0EF-0BA35E257167

P1476

Q24554505-709E8ADC-D1A4-46A8-89D3-CCBE744D922D

P2093

Q24554505-1666CE6C-F06E-482E-A0BB-5C358D70CFA7

Q24554505-3B947F49-E4E4-4694-B293-65BCB078AE78

Q24554505-9AA19AFC-6121-44D1-8F47-798C5E6394A6

P2860

Q24554505-0215ABA5-31CD-4C8F-844A-F0E30EB62296

Q24554505-03059BD9-F25C-4EC3-AD7E-548675A7E0D3

Q24554505-0E32E4F2-EE92-4FDA-8DB1-ADC7C4280F25

Q24554505-17A7F1E4-0D58-4CFF-B66B-DE64B0531DF5

Q24554505-1A64533B-3F38-46BA-8A2E-17EE07465868

Q24554505-1C28ADF6-6D55-43C3-9CC2-C7D428028B69

Q24554505-1E6AD6E0-9C27-4C0C-A0C9-4E6AC39A92D6

Q24554505-2056E6FE-B6B3-4CCA-A709-311AA64B5D2F

Q24554505-260FFC5D-8D6A-46A0-8639-A1025391BDC6

Q24554505-279EDF71-B746-4D9D-A0C0-AE1C1A4A3225

P2888

Q24554505-5B6978F7-71AA-4575-B402-BD167DBC1C2B

P304

Q24554505-75EBBA68-F3F6-42D3-BBDC-F04966810FCA

P31

Q24554505-305720E4-5096-4A29-9A08-2C2FB0EAFE55

P3181

Q24554505-C2CF3683-EF9B-477C-8FE3-52DCBC2BA6C0

P356

Q24554505-1E4F7809-371C-4D40-A6D9-21E799DCA009

P407

Q24554505-26B23CB6-6F14-4F89-81C9-8544BED390D5

P433

Q24554505-008F28C4-08AA-4CCC-A866-1FFE8316BD56

P478

Q24554505-6A95455F-A0AE-439C-A333-95A2D42273C1

P50

Q24554505-E7C88EC2-895E-49D7-BE1D-AA0D7C250985

P577

Q24554505-90888A2B-DD76-4F24-BDCA-E7B4D58239D5

P5875

Q24554505-56DEDD87-32A5-4A4B-927D-ADD5CA6D7144

P6179

Q24554505-E0DFDBD5-CD0A-4CE5-BB5D-22B0EB4D661B

P698

Q24554505-74547A11-5DB8-4A77-8868-21FF0D341822

P921

Q24554505-3D71012A-9754-45B5-BC14-B3A62E7E244E

Q24554505-90cc1f48-f519-4d84-afb0-32ca03ec7fc4

P932

Q24554505-D854A96F-A105-4784-9EA2-710567BF9555

P3181

P356

P1433

BMC Neuroscience

P1476

Serotonin 5-HT2A and 5-HT6 rec ...... imer and normal aging patients

@en

P2093

David T Yew

http://www.w3.org/2001/XMLSchema#string

Dietrich E Lorke

http://www.w3.org/2001/XMLSchema#string

Gang Lu

http://www.w3.org/2001/XMLSchema#string

P2860

The cholinergic hypothesis of Alzheimer's disease: a review of progress

Neuropathological stageing of Alzheimer-related changes

Serotonin model of schizophrenia: emerging role of glutamate mechanisms

A review of central 5-HT receptors and their function

The physiological role of 5-HT2A receptors in working memory

Association of the HTR6 polymorphism C267T with late-onset Alzheimer's disease in Chinese

Cellular and subcellular distribution of the serotonin 5-HT2A receptor in the central nervous system of adult rat

Serotonin 5-HT2a and 5-HT2c receptors stimulate amyloid precursor protein ectodomain secretion

Role of serotonin in the behavioral and psychological symptoms of dementia.

PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.

P2888

P304

36

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4848086

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1471-2202-7-36

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-04-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7139950

http://www.w3.org/2001/XMLSchema#string

P6179

1049526725

http://www.w3.org/2001/XMLSchema#string

P698

16640790

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

1523198

http://www.w3.org/2001/XMLSchema#string